The whistleblower pharmaceutical sales reps in the Procrit case reinstated in a Massachussetts federal court claim that their careers at Johnson & Johnson's Ortho Biotech unit were based mostly on ...

Dear Dr. Roach: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...

Johnson & Johnson is trimming its sales force for anemia drug Procrit, a top-seller that has lost market share recently due to increased competition from Amgen’s Aranesp. Ortho Biotech Products, the J ...

Johnson & Johnson said some of its Procrit anemia treatment was found diluted to greatly reduce the amount of active medicine in the solution, the latest in a string of drug counterfeiting incidents ...

DEAR DR. ROACH: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...

(CN) - The Supreme Court on Monday refused to block a lawsuit against a Johnson & Johnson subsidiary by salesmen who accused the company of giving kickbacks to doctors for prescribing its anemia drug ...

Dear Dr. Donohue: I have been told that the kidneys are the seat of emotions. Is this true? I have chronic kidney disease and have to take shots of Procrit. I heard that this miracle drug has side ...

Amgen and Centocor Ortho Biotech announced a voluntary nationwide recall of certain lots of Epogen (epoetin alfa) and Procrit (epoetin alfa) vials that may contain extremely thin glass flakes ...

Epoetin alfa 10000 Units, 20000 Units; per mL; soln for IV or SC inj; contains albumin (human) and benzyl alcohol. Individualize (see full labeling for titration). CKD: initially 50–100 Units/kg 3 ...

Dec. 2, 2005 -- The US Food and Drug Administration (FDA), Amgen Inc, and Ortho Biotech Clinical Affairs, LLC, have notified healthcare professionals via letter regarding revisions to the safety ...

NEW YORK – Johnson & Johnson (JNJ) has sued Amgen (AMGN), accusing the world's largest biotechnology company of hampering sales of J&J's anemia drug, Procrit (search), by using anti-competitive ...

Products were found to contain thin glass flakes, but their potential to impact patients is expected to be low. Amgen has voluntarily recalled certain lots of Epogen® and Procrit® (epoetin alfa) vials ...